AVITA Medical (ASX:AVH) Updates Q4 and FY2024 Revenue Guidance
AVITA Medical (ASX:AVH) revises its Q4 2024 revenue guidance while forecasting strong growth for 2025.
Category: Healthcare
Orthocell Limited (ASX: OCC) Reports Record Revenue Growth
Orthocell Limited (ASX: OCC) announces record revenue of $2.21 million for December ’24 Quarter, driven by strong sales and international market expansion.
Galan Lithium Limited (ASX:GLN) Receives Full HMW Phase 2 Mining Permit
Galan Lithium (ASX:GLN) secures the mining permit for HMW Phase 2, set to boost lithium production capacity significantly.
Regal Partners Limited (ASX:RPL) Reports Record FUM Growth
Regal Partners (ASX:RPL) reports record net inflows and FUM growth, highlighting potential performance fee revenues of $85 million for 2024.
4DMedical Limited (ASX:4DX) Secures FDA Clearance for IQ-UIP™
4DMedical Limited (ASX:4DX) has secured FDA clearance for IQ-UIP™, enhancing diagnostic capabilities for lung health.
Argent BioPharma Ltd (ASX:RGT) Completes US$4.5 Million Capital Raise
Argent BioPharma Ltd (ASX:RGT) successfully raises US$4.5 million to advance its drug development pipeline.
Syrah Resources Limited (ASX: SYR) Agrees to DFC Loan Waiver
Syrah Resources has secured a waiver on DFC loan defaults due to operational challenges at its Balama site in Mozambique.
BrainChip Holdings (ASX:BRN) Announces Fourth Amendment to LDA Put Option Agreement
BrainChip Holdings secures an additional AUD $20M in its amendment of the Put Option Agreement with LDA Group to support product development.
QEM Limited (ASX:QEM) Secures Key Environmental Approval
QEM Limited secures Controlled Action status for its Julia Creek Vanadium and Energy Project, enhancing its environmental assessment processes.
EBR Systems Inc. (ASX:EBR) Responds to ASX Query on Trading Activity
EBR Systems Inc. (ASX:EBR) confirms no undisclosed information behind recent trading activity in response to ASX inquiry.